We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AliveDx Showcases MosaiQ and LumiQ Systems at ADLM 2026

By LabMedica International staff writers
Posted on 29 Jul 2026

AliveDx is showcasing diagnostic solutions for autoimmune disease, allergy, and transfusion medicine at ADLM 2026, held July 28–30 at the Anaheim Convention Center in California. More...

At booth 4337, visitors can explore platforms designed to shorten time to results, provide clinical insights, and improve laboratory workflows.

A central feature of the exhibit is MosaiQ, AliveDx’s fully automated, high-throughput platform for syndromic multiplex testing. The system combines microarray technology with automated laboratory workflows to enable the simultaneous analysis of multiple markers.

The company is also presenting LumiQ, a compact, all-in-one platform for indirect immunofluorescence assay testing in autoimmune diagnostics. LumiQ automates the workflow from sample processing through image capture, reading, and interpretation to help laboratories standardize IFA testing.

AliveDx is additionally highlighting scientific evidence supporting the performance of MosaiQ assays across vasculitis, autoimmune rheumatic diseases, and celiac disease. Three studies are being presented during the Clinical and Diagnostic Immunology poster session on July 29.

One poster evaluates a multiplex microarray immunoassay for the simultaneous detection of anti-MPO, anti-PR3, and anti-GBM autoantibodies. A second examines the detection of 15 autoantibodies associated with autoimmune rheumatic diseases, while the third compares the clinical performance of a multiplexed microarray immunoassay for celiac disease autoantibodies in a pediatric population.

Through its ADLM 2026 exhibit, AliveDx is demonstrating how automated multiplex and immunofluorescence technologies can help laboratories consolidate workflows, improve standardization, and provide faster diagnostic information.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.